Arbutus Biopharma Corp Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Arbutus Biopharma Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.18M, a 7.29% increase year-over-year.
  • Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.4M, a 10.9% increase year-over-year.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2023 was $9.3M, a 29.5% increase from 2022.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2022 was $7.18M, a 11.8% increase from 2021.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2021 was $6.42M, a 4.27% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.3M +$2.12M +29.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $7.18M +$758K +11.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $6.42M +$263K +4.27% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $6.16M -$638K -9.38% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $6.8M +$792K +13.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $6.01M -$9.11M -60.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $15.1M -$24M -61.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $39.2M +$17.1M +77.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $22.1M +$18.8M +573% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $3.28M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.